The molecular characterization of genetic abnormalities in esophageal squamous cell carcinoma may foster the development of targeted therapies

HIGHLIGHTS

  • who: Ugo Testa and colleagues from the Department of Oncology, Istituto Superiore di Sanitu00e0, Viale Regina Elena, Rome, Italy have published the research work: The Molecular Characterization of Genetic Abnormalities in Esophageal Squamous Cell Carcinoma May Foster the Development of Targeted Therapies, in the Journal: (JOURNAL)
  • what: This analysis showed clear evidence of selection during clonal expansion in normal esophagi for the 74 genes investigated: dN/dS ratios for missense and protein-truncating mutations were 2.2 and 8.6, respectively, with the enrichment of non-synonymous mutations increasing rapidly with clone size . This study . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?